Dr. Etra is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10 E 102nd St
New York, NY 10029Phone+1 212-241-6756
Education & Training
- Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 2015 - 2018
- Icahn School of Medicine at Mount Sinai/Beth IsraelResidency, Internal Medicine, 2012 - 2015
- Albert Einstein College of MedicineClass of 2012
- Icahn School of Medicine at Mount Sinai/Beth IsraelInternship, Internal Medicine
Certifications & Licensure
- FL State Medical License 2021 - Present
- NY State Medical License 2015 - 2027
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Autologous Stem Cell Transplant for Crohn's Disease Start of enrollment: 2017 Jul 12
Roles: Contact, Principal Investigator, Sponsor-Investigator
Publications & Presentations
PubMed
- 1 citationsIbrutinib for therapy of steroid-refractory chronic graft-versus-host disease: a multicenter real-world analysis.Joseph Pidala, Jongphil Kim, Denise Kalos, Corey Cutler, Zachariah DeFilipp
Blood Advances. 2025-03-11 - Reparative immunological consequences of stem cell transplantation as a cellular therapy for refractory Crohn's disease.Daniela Guisado, Sayali Talware, Xiaoli Wang, Andrew Davis, Elbek Fozilov
Gut. 2025-02-17 - Serial Clinical and Biomarker Monitoring during Graft-Versus-Host Disease Treatment Identifies Distinct Risk Strata Including an Ultra-Low Risk Group.Nikolaos Katsivelos, Nikolaos Spyrou, Daniela Weber, Ingrid Vasova, Francis Ayuk
Transplantation and Cellular Therapy. 2025-01-01
Press Mentions
- Itacitinib Appears Effective for Acute Graft-Versus-Host DiseaseFebruary 12th, 2023
- Mount Sinai Researchers Find New, Safer Treatment for Serious Side Effect of Bone Marrow TransplantDecember 13th, 2022
Professional Memberships
- Member
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: